U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Triamcinolone Acetonide Injectable Suspension
Status: Currently in Shortage
»Date first posted: 09/27/2021
»Therapeutic Categories: Ophthalmology

Novartis (Reverified 08/11/2022)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40mg/mL vial, 1mL in 1 vial (NDC 0065-0543-01) Availability through wholesalers: not available. Estimated duration of supply shortage: 3-18 months. Requirements related to complying with good manufacturing practices
Back to Top